Radiopharm Theranostics Limited
RADX
$7.03
-$0.42-5.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.12% | -0.85% | 2.75% | 21.57% | -0.21% |
| Total Depreciation and Amortization | 2.13% | -31.56% | -2.74% | -50.66% | 0.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.12% | 293.35% | 2.75% | -275.96% | 0.21% |
| Change in Net Operating Assets | -2.12% | -- | -- | -- | 0.21% |
| Cash from Operations | -2.12% | 37.48% | 2.75% | -101.64% | -0.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.10% | -139.41% | -2.75% | 1,052.85% | -0.19% |
| Cash from Investing | -2.10% | -139.41% | -2.75% | 1,052.85% | -0.19% |
| Total Debt Issued | -- | -- | -- | -- | 0.00% |
| Total Debt Repaid | -- | 100.00% | 0.00% | 13.64% | 0.00% |
| Issuance of Common Stock | 0.00% | -82.25% | 0.00% | 66.51% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 109.37% | 0.00% | -383.70% | 0.00% |
| Cash from Financing | 2.12% | -76.80% | -2.75% | 31.92% | 0.21% |
| Foreign Exchange rate Adjustments | -2.16% | -199.28% | -2.78% | 3,693.18% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.12% | -139.45% | -2.75% | 8.88% | 0.21% |